Table: begin end state 1 32 cytoplasmic 33 56 transmembrane 57 66 non-cytoplasmic 67 91 transmembrane 92 105 cytoplasmic 106 134 transmembrane 135 167 non-cytoplasmic 168 186 transmembrane 187 196 cytoplasmic 197 217 transmembrane 218 236 non-cytoplasmic 237 256 transmembrane 257 275 cytoplasmic 276 301 transmembrane 302 320 non-cytoplasmic 321 343 transmembrane 344 372 cytoplasmic 373 392 transmembrane 393 397 non-cytoplasmic 398 417 transmembrane 418 429 cytoplasmic 430 450 transmembrane 451 455 non-cytoplasmic 456 475 transmembrane 476 481 cytoplasmic
Input: >WP_102938052.1 NCBI__GCF_002117405.1:WP_102938052.1 MLTRSRSVYFSRKSIHLVIAENDAEENGLKRALGWASLMAMGIGGIIGAGIFVLTGQAAA DYAGPGVTISFLLSGLACTFVALCYAELAALIPAAGSTYTYTYVTLGEIFAWIIGWNLVL EYAAGAATVAVGWAGYFNRVMQGLGIHLPEALTSAYFANAHSIGGTHGVFNVPAAAIILL LTALLMRGTSESSFFNNIIVVIKVMVVLVVIFVGAAHVDAANWTPLIPENTDHFGHFGWS GVVRGASVVFFAYIGFDGVSTAAQEAHTPQRDVPIGILGSLVICTILYVAVAAVATGVVS YKELGVPDPMALVMDRTGVAWLSWVVKLGAIAGLTTAILLLLFGQTRIFYAMAQDGLLPK VFAAVHPVWRTPAVSQALVGVFVALAAGLFPINILDEMVSIGTLAAFALVCGAVLHLRRS QPDMHRPFRAPGIPAMPLLGIASCLALMVALPLETWLRLIVWTAIGMAIYFFYGVKHAKR A
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server